Acute lymphoblastic leukemia: Comprehensive pediatric CAR T guidelines developed

Acute lymphoblastic leukemia: Comprehensive pediatric CAR T guidelines developed

Almost one year after the US Food and Drug Administration (FDA) approval of chimeric antigen receptor (CAR) T-cell therapy for children with acute lymphoblastic leukemia (ALL), researchers have recently published treatment guidelines for managing the treatment.

  • 0 Likes

  • 0 Comments